Sarama Completes Tranche 2 Equity Placement And ASX Cleansing Notice
The placement adds exploration and working-capital funding, while final TSX Venture Exchange approval remains pending.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Sarama Resources (SRMMF) completed the second tranche of its equity placement, raising gross proceeds of A$81,750 through securities issued to directors. The tranche comprised 2,335,715 CHESS Depository Instruments (CDIs) at A$0.035 each. Each CDI represents a beneficial interest in one common share and ranks equally with existing CDIs.
The first tranche, completed on 29 May 2026, raised A$1,418,250 through 40,521,427 CDIs at the same price. The placement was issued to existing shareholders and institutional investors. Board and management subscriptions totalled 2,907,143 CDIs across the placement. Shareholders approved the second-tranche director subscriptions at the 21 October 2026 meeting in Vancouver. Funds will support exploration projects and general working capital. Final TSX Venture Exchange approval remains pending.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointSecond-tranche completion raised A$81,750 in gross proceeds from director subscriptions.
- Minor pointFirst-tranche completion on 29 May 2026 raised A$1,418,250 in gross proceeds.
- Minor pointShareholder approval for second-tranche director subscriptions was obtained on 21 October 2026 in Vancouver.
Negative
- Moderate pointNew issuance dilutes holders: 2,335,715 second-tranche CDIs and 40,521,427 first-tranche CDIs, each priced at A$0.035.
- Minor pointThe placement remains subject to final TSX Venture Exchange approval.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VANCOUVER, BC AND PERTH, AU / ACCESS Newswire / October 27, 2026 / Sarama Resources Ltd. ("Sarama" or the "Company") (TSX-V:SWA)(ASX:SRR) advises that on 27 October 2026, it completed tranche 2 ("Tranche 2") of its previously announced A
Tranche 2 of the Placement raised aggregate gross proceeds of A
Tranche 1 of the Placement completed on 29 May 2026, raised aggregate gross proceeds of A
The Placement was issued to existing shareholders and institutional investors.
Funds raised will be used to progress the Company's exploration projects and for general working capital purposes as the Company pursues its US
Members of Sarama's board and management subscribed for an aggregate 2,907,143 CDls in the Placement (inclusive of the Director CDIs issued in Tranche 2).
The Placement remains subject to the final approval of the TSX Venture Exchange ("TSXV"). The CDIs issued to Sarama's directors and management under Tranche 1 and Tranche 2 of the Placement are subject to the TSXV's four month hold period. All other subscribers under Tranche 1 of the Placement were not subject to any hold period.
Each director or officer that participates in the Placement is a "related party" of the Company within the meaning of that term in Canadian Multilateral Instrument 61-101 - Protection of Minority Shareholders in Special Transactions ("MI 61-101"). Participation by them in the Placement is therefore a "related party transaction" within the meaning of MI 61-101. Pursuant to Section 5.5(a) and 5.7(1)(a) of MI 61-101, the Company was exempt from obtaining a formal valuation and minority approval of the Company's shareholders in respect of the Placement due to the fair market value of their participation being below
The Placement securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from registration is available. This announcement does not constitute an offer to sell or a solicitation of an offer to buy any of the Placement securities within the United States or to, or for the account or benefit of, U.S. Persons (as defined under Regulation S under the U.S. Securities Act), nor shall there be any sale of these Securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)
This notice is given by Sarama Resources Ltd. (ARBN 143 964 649) ("Company") under section 708A(5)(e) of the Corporations Act 2001 ("Corporations Act") as modified by ASIC Corporations (Offers of CHESS Depository Interests) Instrument 2025/180 ("Instrument").
1. The CDIs were issued without disclosure to investors under Part 6D.2 of the Corporations Act.
2. This notice is being given under section 708A(5)(e) of the Corporations Act.
3. The Company, as at the date of this notice, has complied with:
a) the provisions of section 601CK of the Corporations Act as they apply to the Company; and
b) sections 674 and 674A of the Corporations Act.
4. As at the date of this notice, there is no information, for the purposes of section 708A(7) and 708A(8):
a) that has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules;
and
b) that investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:
(i) the assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or
(ii) the rights and liabilities attaching to the CDIs.
Where applicable, references in this notice to sections of the Corporations Act are to those sections as modified by the Instrument.
This announcement was authorised by the board of Sarama.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Company Activities
Andrew Dinning
Sarama Resources Ltd
e: info@saramaresources.com
t: +61 8 9363 7600
CAUTION REGARDING FORWARD LOOKING INFORMATION
Information in this news release that is not a statement of historical fact constitutes forward-looking information. Such forward-looking information includes, but is not limited to, statements regarding the intended use of proceeds from the Placement, including any timeline for the use thereof and any objectives to be achieved from the use thereof, the success of the Claim or the quantum of damages associated therewith, timing for filing a material change report, and timing and receipt of approval from the TSXV for the Placement. Actual results, performance or achievements of the Company may vary from the results suggested by such forward-looking statements due to known and unknown risks, uncertainties, and other factors. Such factors include, among others, that the business of exploration for gold and other precious minerals involves a high degree of risk and is highly speculative in nature; mineral resources are not mineral reserves, they do not have demonstrated economic viability, and there is no certainty that they can be upgraded to mineral reserves through continued exploration; few properties that are explored are ultimately developed into producing mines; geological factors; the actual results of current and future exploration; changes in project parameters as plans continue to be evaluated; risks related to the success of the Claim; as well as those factors disclosed in the Company's publicly filed documents.
Readers should not place undue reliance on forward-looking information and Sarama does not undertake to update any forward-looking information, except as required by applicable laws.
SOURCE: Sarama Resources Ltd.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much did Sarama raise in the second tranche, and at what price?
Sarama raised A$81,750 in gross proceeds by issuing 2,335,715 CDIs at A$0.035 per CDI. The second tranche was completed on 27 October 2026, with the securities issued to directors.
What holding restrictions apply to Sarama directors and management in the placement?
CDIs issued to Sarama directors and management under both tranches are subject to a four-month TSX Venture Exchange hold period from their issue date. Other first-tranche subscribers were not subject to any hold period.
Why was Sarama exempt from formal valuation and minority approval requirements for insider participation?
Sarama qualified for exemptions under MI 61-101 because the fair market value of insider participation was below 25% of its market capitalization for that instrument's purposes. These exemptions covered formal valuation and minority shareholder approval requirements for the related-party participation.